TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan · Delayed Price · Currency is TWD 55.70
+0.30 (0.54%)
Jan 22, 2026, 1:30 PM CST
TSH Biopharm Corporation Market Cap
TSH Biopharm Corporation has a market cap or net worth of 2.13 billion as of January 21, 2026. Its market cap has decreased by -9.03% in one year.
Market Cap
2.13B
Enterprise Value
1.49B
Revenue
1.27B
Ranking
n/a
PE Ratio
17.04
Stock Price
55.70
Market Cap Chart
Since June 16, 2011, TSH Biopharm Corporation's market cap has increased from 1.96B to 2.13B, an increase of 8.41%. That is a compound annual growth rate of 0.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 2.13B | -5.30% |
| Dec 31, 2025 | 2.25B | -4.57% |
| Dec 31, 2024 | 2.35B | 21.87% |
| Dec 29, 2023 | 1.93B | 5.78% |
| Dec 30, 2022 | 1.83B | 6.85% |
| Dec 30, 2021 | 1.71B | -24.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maywufa Company | 2.91B |
| Golden Biotechnology | 2.90B |
| PhytoHealth | 2.76B |
| Johnson Chemical Pharmaceutical Works | 2.74B |
| Allied Biotech | 2.53B |
| LIWANLI Innovation | 2.44B |
| GeneFerm Biotechnology | 1.90B |
| InnoPharmax | 1.77B |